[1] Gorski, J.C., Jones, D.R., Haehner-Daniels, B.D., Hamman, M.A., O’Mara Jr., E.M. and Hall, S.D. (1998) The Contribution of Intestinal and Hepatic CYP3A to the Interaction between Midazolam and Clarithromycin. Clinical Pharmacology and Therapeutics, 64, 133-143.
http://dx.doi.org/10.1016/S0009-9236(98)90146-1
[2] Kronbach, T., Mathys, D., Umeno, M., Gonzalez, F.J. and Meyer, U.A. (1989) Oxidation of Midazolam and Triazolam by Human Liver Cytochrome P450IIIA4. Molecular Pharmacology, 36, 89-96.
[3] Kostrubsky, V.E., Szakacs, J.G., Jeffery, E.H., Wood, S.G., Bement, W.J., Wrighton, S.A., Sinclair, P.R. and Sinclair, J.F. (1997) Role of CYP3A in Ethanol-Mediated Increases in Acetaminophen Hepatotoxicity. Toxicology and Applied Pharmacology, 143, 315-323.
http://dx.doi.org/10.1006/taap.1996.8081
[4] Feierman, D.E. (2000) The Effect of Paracetamol (Acetaminophen) on Fentanyl Metabolism in Vitro. Acta Anaesthesiologica Scandinavica, 44, 560-563.
http://dx.doi.org/10.1034/j.1399-6576.2000.00513.x